Concepedia

Gwynn Pardee

GP

Statistics

Publications

7

Citations

973

H-Index

7

Active since

1994

Affiliations

Novartis (United States)(Current)

Novartis (Switzerland)

Novartis Institutes for BioMedical Research

Gwynn Pardee is an author at Novartis (United States) specializing in life sciences, structural biology, and pharmacology.

Publications per year

1994–2023

7

Publications

7

Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo

William E. Dowdle, Beat Nyfeler, Jane Nagel et al. · Nature Cell Biology · 2014 · 740 citations

, , +16

LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors

Kelli‐Ann Monaco, Scott Delach, Jing Yuan et al. · Clinical Cancer Research · 2020 · 88 citations · Full text

, , +17

Rationally Designed PI3Kα Mutants to Mimic ATR and Their Use to Understand Binding Specificity of ATR Inhibitors

Yipin Lu, Mark Knapp, Kenneth Crawford et al. · Journal of Molecular Biology · 2017 · 40 citations · Full text

, , +14

Baculovirus-driven protein expression in insect cells: A benchmarking study

Peggy Stolt-Bergner, Christian Benda, Tim Bergbrede et al. · Journal of Structural Biology · 2018 · 34 citations

, , +6

Inhibition of prenylated KRAS in a lipid environment

Johanna M. Jansen, Charles Wartchow, Wolfgang Jahnke et al. · PLoS ONE · 2017 · 31 citations · Full text

, , +17

1–5 of 7